Literature DB >> 4056242

Stabilizing effect of epsilon-aminocaproic acid on allergenic extracts.

E M Van Hoeyveld, E A Stevens.   

Abstract

The effect of epsilon-aminocaproic acid (EACA) on the degradation of an aqueous Lolium perenne extract was studied by intracutaneous tests and by RAST inhibition. Extracts for skin testing stored at 4 degrees C for 12 months and at 37 degrees C for 6 weeks were significantly protected from degradation by addition of 0.1 mol/L of EACA before storage. Extracts were stored for RAST inhibition at 4 degrees C for 6 months and at 37 degrees C for 7 days. Shelf life was twofold to threefold increased when 0.1 mol/L of EACA was added to the dilution medium. EACA also protected the extracts from the effect of freezing and thawing. Comparison with the effect of human serum albumin indicated a rather short activity of human serum albumin, whereas the effect of EACA lasted longer. It is suggested that EACA can be used to increase the stability of aqueous allergen extracts for skin testing and for hyposensitization therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4056242     DOI: 10.1016/0091-6749(85)90773-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  2 in total

1.  2-Year-Old and 3-Year-Old Italian ALS Patients with Novel ALS2 Mutations: Identification of Key Metabolites in Their Serum and Plasma.

Authors:  Mukesh Gautam; Renata Del Carratore; Benjamin Helmold; Alessandra Tessa; Oge Gozutok; Navdeep Chandel; Halil Idrisoglu; Paolo Bongioanni; Roberta Battini; P Hande Ozdinler
Journal:  Metabolites       Date:  2022-02-12

2.  Preparation of chemically stable allergen-specific sublingual immunotherapy from Egyptian allergens.

Authors:  Mohammed A Abu El-Enin; Eman M Rabie Shehab El-Din; Heba Wagih Abdelwahab; Amina Abd El-Maksoud; Abeer M Abd El-Aziz; Mona I Shaaban; Ahmed Nader Attia; Wafaa A Aboukamar; Sanaa Mohei-Aldin; Fathalla Belal
Journal:  J Clin Lab Anal       Date:  2022-02-11       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.